Induced pluripotent stem cells (iPSCs) are a unique type of stem cell that can be developed from somatic cells by inserting genes that transform them into an embryonic-like state. These artificially-developed pluripotent cells can proliferate and self-renew indefinitely in vitro, as well as differentiate into different types of specialized cells. [Read more…]
Bordeaux, France – November, 17th, 2020 —The French Blood Agency (EFS) and TreeFrog Therapeutics announce a partnership to advance the mass-production of iPSC-derived HSC transplants based on a patented differentiation protocol developed by the EFS (UMR S938), the Institute for Radioprotection and Nuclear Safety (IRSN) and Sorbonne University[1]. [Read more…]